Cowen and Company’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Cowen and Company’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,230	Closed	-$264K	–	507
2020 Q3	$264K	Buy	+1,230	New	+$265K	0.04%	190
2019 Q4	–	Sell	-5,406	Closed	-$1.12M	–	576
2019 Q3	$1.12M	Buy	+5,406	New	+$1.11M	0.28%	62

Other funds holding RVPH

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Cowen and Company's RVPH Position: Q4 2020 in Review

Cowen and Company sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2020, closing a stake of 1,230 shares — an estimated $264K sold.

Cowen and Company first reported a position in RVPH in Q3 2019 and held it in 2 quarters. The position peaked at $1.12M in Q3 2019. 3 funds tracked by Wall St. Rank hold RVPH as of Q4 2020.

Cowen and Company reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2020 after selling out during the quarter.
Cowen and Company sold 1,230 REVIVA PHARMA HLDGS INC shares in Q4 2020, an estimated $264K.
Cowen and Company first reported a position in REVIVA PHARMA HLDGS INC in Q3 2019 and held it in 2 quarters.
Cowen and Company's REVIVA PHARMA HLDGS INC position peaked at $1.12M in Q3 2019.
3 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2020.

Based on Cowen and Company's 13F filing for Q4 2020, filed 8 Feb 2021.